DUBLIN, Nov 22, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Cancer Vaccines: Technologies and Global Markets" report to their offering.
The global market for cancer vaccines was valued at nearly $4.2 billion and $4.0 billion in 2014 and 2015, respectively. This market is expected to decline from nearly $3.5 billion in 2016 to $3.4 billion in 2021 at a compound annual growth rate (CAGR) of -0.4% for 2016-2021.
This report provides:
- An overview of the global markets and technologies for cancer vaccines.
- Analyses of global market trends, with data from 2014 and 2015, estimates for 2016, and projections of CAGRs through 2021.
- Coverage of the cancer vaccines arena including diverse therapeutic platform technologies, immune-stimulating agents and approved vaccines for cancer.
- Examination of the governmental and regulatory environment and how its effecting the market.
- Information on new developments including products in Phase I-IV clinical trials, as well as new technologies.
- Analysis of the market's dynamics, specifically growth and restriction factors, acquisitions and collaborations, and a look at the cancer vaccine market's current achievements and future challenges.
- Relevant patent analysis, presented by year and by vaccine type.
The scope of this study entails the global market of cancer vaccines. The report covers the total market of cancer vaccines, which includes two main areas of applications, prophylactic vaccines and therapeutic vaccines. Human papillomavirus (HPV) vaccines and hepatitis B vaccines that indirectly act against cancer are also included in the report.
Companies Mentioned Include:
- Adamis Pharmaceuticals Corp.
- Aduro Biotech Inc.
- Advantagene Inc.
- Advaxis Inc.
- Alphavax Inc.
- Altor Bioscience Corp.
- Antigen Express Inc.
- Bavarian Nordic A/S
- Bellicum Pharmaceuticals
- Biovest International Inc.
- Cascadian Therapeutics Inc.
- Celldex Therapeutics
- Curevac AG
- Newlink Genetics Corp.
- Novarx Corp.
- Oncovir Inc.
- Oxford Biomedica Plc
- Sotio AS
- Ubivac Llc
- Vical Inc.
- Vaccinogen Inc.
- Vaxon Biotech
Report Structure:
1: Introduction
2: Executive Summary
3: Overview
4: Regulatory Aspects
5: New Developments
6: Market Analysis
7: Industry Structure
8: Market By Application
9: Patent Analysis
10: Current Situation
11: Company Profiles
12: Abbreviations
For more information about this report visit http://www.researchandmarkets.com/research/mnb7hp/cancer_vaccines
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article